Scott Mc Menemy
About Scott Mc Menemy
Scott Mc Menemy serves as the Vice President of Business Development and Sales at Alloy Therapeutics, where he focuses on empowering drug discovery across various biologic modalities. He has extensive experience in the biopharma and biotech sectors, having held key roles at Nexcelom Bioscience and other organizations, and he holds degrees from Harvard Business School Online and the University of Aberdeen.
Current Role at Alloy Therapeutics
Scott Mc Menemy serves as the Vice President of Business Development and Sales at Alloy Therapeutics, Inc. since 2023. In this role, he focuses on empowering drug discovery across six biologic modalities. He leverages a broad portfolio of products, services, and industry insights to address technical, business, and organizational challenges for partners and the broader ecosystem. His work aims to drive innovation in the development and manufacturing of cell and gene therapies, ultimately widening patient access.
Previous Experience in Business Development
Before joining Alloy Therapeutics, Scott Mc Menemy held several positions at Nexcelom Bioscience. He worked as the Regional Business Manager for New England and Eastern Canada from 2016 to 2021, and as the Business Development Manager for the Trans-Atlantic Region from 2016 to 2020. He also served as the UK Technical Sales and Business Development Manager from 2014 to 2016. Additionally, he was the North America Sales Leader at Cell Microsystems from 2022 to 2023 and the Global Key Account Leader at PerkinElmer, Inc. from 2021 to 2022.
Educational Background
Scott Mc Menemy studied Biomedical Sciences and Human Anatomy at the University of Aberdeen, where he earned a Bachelor of Science (Honours) from 2004 to 2009. He furthered his education at Harvard Business School Online, completing the CORE: Credential of Readiness program in 2019, which included courses in Economics for Managers, Business Analytics, and Financial Accounting. He also achieved Negotiation Mastery in 2020 and completed a course on Launching Tech Ventures in 2023.
Research and Academic Experience
Scott Mc Menemy was a Siddal PhD Scholar at the University of Aberdeen from 2009 to 2012. This role involved research that contributed to his understanding of biomedical sciences. His academic background has provided him with a strong foundation in the scientific principles that underpin the biopharma and biotech industries.
Focus on Cell and Gene Therapies
Scott Mc Menemy has a passion for addressing challenges in the development and manufacturing of cell and gene therapies. His work is centered on driving innovation in this field, with the goal of improving patient access to advanced therapies. He has a proven track record of building strong relationships with global biopharma and biotech clients, which supports his efforts in this area.